The FDA has a new Transparency Blog, as Bertalan Meskó points out, that will run for the next six months to "discuss various ways in which the Food and Drug Administration (FDA) could provide information to the public about what FDA is doing, the bases for FDA's decisions, and the processes used to make agency decisions." The first question the Transparency Blog poses is general: "How can the agency better explain its operations, activities, processes and decision making?" Head on over to their comments section to give your two cents' worth.
Premium Trial: